Our team is investigating the differences between healthy older individuals and those with Cerebral Amyloid Angiopathy (CAA), a form of stroke-related dementia. We hope to identify biological markers through MRIs, memory/attention testing, and optional spinal fluid samples to learn about the progression of both CAA and memory loss. 

Study Duration: 3-4 visits to MGH over 2 years

Participants: At least 55 years of age and diagnosed with Cerebral Amyloid Angiopathy.

Compensation: $500 for completeing the study and parking and lunch will be covered.

If you are interested, please contact Vanessa Gonzalez at